DAVID R. EBSWORTH - 01 May 2025 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role
Director
Signature
/s/ Andrew Fisher, Attorney-in-fact for David R. Ebsworth
Issuer symbol
VRNA
Transactions as of
01 May 2025
Transactions value $
$270,732
Form type
4
Filing time
05 May 2025, 16:30:54 UTC
Previous filing
29 Apr 2025
Next filing
05 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
EBSWORTH DAVID R Director 3 MORE LONDON RIVERSIDE, LONDON, UNITED KINGDOM /s/ Andrew Fisher, Attorney-in-fact for David R. Ebsworth 05 May 2025 0001207107

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRNA Ordinary Shares Options Exercise $271K +140K +10.48% $1.93 1.48M 01 May 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRNA Stock Option (Right to Exercise) Options Exercise $0 +140K $0.00 0 01 May 2025 Ordinary Shares 140K $1.93 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 Consists of (i) 1,476,000 Ordinary Shares represented by 184,500 ADSs and (ii) 3 Ordinary Shares.
F3 The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F4 The option is fully vested.